Original Literature | Model OverView |
---|---|
Publication
Title
Pathways connecting inflammation and cancer.
Affiliation
Istituto Clinico Humanitas IRCCS, Via Manzoni 56, 20089 Rozzano, Milan, Italy.
Abstract
Chronic and persistent inflammation contributes to cancer development and canpredispose to carcinogenesis. Infection-driven inflammations are involved in thepathogenesis of approximately 15-20% of human tumors. However, even tumors thatare not epidemiologically linked to pathogens are characterized by the presenceof an inflammatory component in their microenvironment. Hallmarks ofcancer-associated inflammation include the presence of infiltrating leukocytes,cytokines, chemokines, growth factors, lipid messengers, and matrix-degradingenzymes. Schematically, two interrelated pathways link inflammation and cancer:(1) genetic events leading to neoplastic transformation promote the constructionof an inflammatory milieu; (2) tumor-infiltrating leukocytes, in particularmacrophages, are prime regulators of cancer inflammation. Thus, an intrinsicpathway of inflammation (driven in tumor cells), as well as an extrinsic pathway(in tumor-infiltrating leukocytes) have been described and both contribute totumor progression.
PMID
18325755
|
Entity
CXCR4
--
G010586
cso30:c:mRNA
cso30:i:CC_CellComponent
--
csml-variable:Double
m93541
10
infinite
0
TRANSFAC | G010586 |
--
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m13
10
infinite
0
TRANSPATH | MO000000058 |
--
IL-1
--
MO000000214
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m185
10
infinite
0
TRANSPATH | MO000000214 |
--
CXCR4
--
MO000017157
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2033
10
infinite
0
InterPro | IPR000276 |
TRANSPATH | MO000017157 |
--
fibronectin
--
MO000017549
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m2341
10
infinite
0
InterPro | IPR006209 |
TRANSPATH | MO000017549 |
--
SIGIRR
--
MO000066718
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m41575
10
infinite
0
TRANSPATH | MO000066718 |
--
L-selectin
--
MO000089774
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m63356
10
infinite
0
TRANSPATH | MO000089774 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
TLR4:Hyaluronan
--
e11
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m11
0
infinite
0
--
TLR4:Hsp60
--
e12
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m12
0
infinite
0
--
NF-kappaB{active}
--
e13
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m14
10
infinite
0
TRANSPATH | MO000000058 |
--
cytokines
--
e14
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m15
0
infinite
0
--
ROI
--
e15
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m16
0
infinite
0
--
IL-1R:ligand:MyD88
--
e16
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m17
0
infinite
0
--
IL-1R:ligand:MyD88:SIGIRR
--
e17
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m18
0
infinite
0
--
IL-1R:ligand:MyD88:IRAK:TRAF6
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m19
0
infinite
0
--
TLR4:ligand:MyD88
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
TLR4:ligand:MyD88:SIGIRR
--
e20
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m21
0
infinite
0
--
TLR4:ligand:MyD88:IRAK:TRAF6
--
e21
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m22
0
infinite
0
--
Ras
--
e22
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m23
0
infinite
0
--
IL-8
--
e23
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m24
0
infinite
0
--
Braf
--
e24
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m25
0
infinite
0
--
Cytokine
--
e25
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m26
0
infinite
0
--
Cytokine
--
e26
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m27
0
infinite
0
--
VEGF
--
e27
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m28
0
infinite
0
--
FGF
--
e28
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m29
0
infinite
0
--
Chemokines
--
e29
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m30
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
FGF
--
e30
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m31
0
infinite
0
--
TGFbeta
--
e31
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m32
0
infinite
0
--
Chemokines
--
e32
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m33
0
infinite
0
--
MMP2
--
e33
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m34
0
infinite
0
--
MMP9
--
e34
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m35
0
infinite
0
--
PDGF
--
e35
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m36
0
infinite
0
--
urokinase plasminogen activator
--
e36
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m37
0
infinite
0
--
urokinase plaminogen activator
--
e37
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m38
0
infinite
0
--
uPAR
--
e38
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m39
0
infinite
0
--
CCL18
--
e39
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m40
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
CCL17
--
e40
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m41
0
infinite
0
--
CCL17
--
e41
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m42
0
infinite
0
--
CCL22
--
e42
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m43
0
infinite
0
--
CCL22
--
e43
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m44
0
infinite
0
--
CCL17:CCR4
--
e44
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m45
0
infinite
0
--
CCL22:CCR4
--
e45
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m46
0
infinite
0
--
CCL2
--
e46
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m47
0
infinite
0
--
CCL20
--
e47
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m48
0
infinite
0
--
L-selectin
--
e48
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m49
0
infinite
0
--
TLR4:fibronectin
--
e5
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
Hyaluronan
--
e6
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
p1
p1
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m2341*m3961*0.1
nodelay
--
0
PMID: 18325755,17324405 Interestingly, TLR4 could also be activated by endogenous ligands produced during stress or cell damage, including heat-shock protein 60, ED-A domain of fibronectin, and hyaluronan
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c30 : 1
stoichiometry:c31 : 1
stoichiometry:c32 : 1
m20*m41575*0.1
nodelay
--
0
PMID: 18325755,14673019,12925853 There is now evidence that TIR8, an orphan member of the IL-1R family (also known as single immunoglobulin IL-1R-related molecule, SIGIRR) inhibits signalling from the IL-1R/TLR complexes, possibly by trapping IRAK-1 and TRAF-6
p9
p11
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c34 : 1
stoichiometry:c35 : 1
stoichiometry:c37 : 1
stoichiometry:c36 : 1
m20*m184*m183*0.1
nodelay
--
0
PMID: 18325755,14673019,12925853 There is now evidence that TIR8, an orphan member of the IL-1R family (also known as single immunoglobulin IL-1R-related molecule, SIGIRR) inhibits signalling from the IL-1R/TLR complexes, possibly by trapping IRAK-1 and TRAF-6
p12
p12
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c39 : 1
stoichiometry:c41 : 1
stoichiometry:c40 : 1
m19*m13*0.1
nodelay
--
0
PMID: 18325755,12925853,14715412 Tir8 gene transfer experiments have revealed that it reduces NF-¦ÊB activation by the IL-1R complex ,as well as by members of the TLR family such as TLR4
p12
p13
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c43 : 1
stoichiometry:c45 : 1
stoichiometry:c44 : 1
m22*m13*0.1
nodelay
--
0
PMID: 18325755,12925853,14715412 Tir8 gene transfer experiments have revealed that it reduces NF-¦ÊB activation by the IL-1R complex ,as well as by members of the TLR family such as TLR4
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c47 : 1
m106169*0.1
nodelay
--
0
PMID: 18325755,12925853,14715412 Tir8 gene transfer experiments have revealed that it reduces NF-¦ÊB activation by the IL-1R complex ,as well as by members of the TLR family such as TLR4
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c49 : 1
m23*0.1
nodelay
--
0
PMID; 18325755,15542429 Transfer of activated ras oncogene into a cervical carcinoma line (HeLa) induces IL-8/CXCL8 production that is sufficient to promote angiogenesis and tumor progression
p16
p16
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c52 : 1
stoichiometry:c51 : 1
m24*m1688*0.1
nodelay
--
0
PMID; 18325755,15542429 Transfer of activated ras oncogene into a cervical carcinoma line (HeLa) induces IL-8/CXCL8 production that is sufficient to promote angiogenesis and tumor progression
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c54 : 1
stoichiometry:c55 : 1
m25*m26*0.1
nodelay
--
0
PMID: 18325755,16801397 Braf, frequently activated in malignant melanoma, induces cytokine production that contributes to pro-tumor milieu
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c59 : 1
m94056*0.1
nodelay
--
0
PMID: 18325755 TAM contribute to tumor progression and invasion also by expressing molecules that directly affect tumor cell proliferation and dissolution of connective tissues. These include epidermal growth factor (EGF), members of the FGF family, TGF¦Â, VEGF, chemokines, and cytokines
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c61 : 1
m93629*0.1
nodelay
--
0
PMID: 18325755 TAM contribute to tumor progression and invasion also by expressing molecules that directly affect tumor cell proliferation and dissolution of connective tissues. These include epidermal growth factor (EGF), members of the FGF family, TGF¦Â, VEGF, chemokines, and cytokines
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m6*m3961*0.1
nodelay
--
0
PMID: 18325755,17324405 Interestingly, TLR4 could also be activated by endogenous ligands produced during stress or cell damage, including heat-shock protein 60, ED-A domain of fibronectin, and hyaluronan
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c63 : 1
m31*0.1
nodelay
--
0
PMID: 18325755 TAM contribute to tumor progression and invasion also by expressing molecules that directly affect tumor cell proliferation and dissolution of connective tissues. These include epidermal growth factor (EGF), members of the FGF family, TGF¦Â, VEGF, chemokines, and cytokines
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c65 : 1
m26*0.1
nodelay
--
0
PMID: 18325755 TAM contribute to tumor progression and invasion also by expressing molecules that directly affect tumor cell proliferation and dissolution of connective tissues. These include epidermal growth factor (EGF), members of the FGF family, TGF¦Â, VEGF, chemokines, and cytokines
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c57 : 1
m32*0.1
nodelay
--
0
PMID: 18325755 TAM contribute to tumor progression and invasion also by expressing molecules that directly affect tumor cell proliferation and dissolution of connective tissues. These include epidermal growth factor (EGF), members of the FGF family, TGF¦Â, VEGF, chemokines, and cytokines
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c67 : 1
m30*0.1
nodelay
--
0
PMID: 18325755 TAM contribute to tumor progression and invasion also by expressing molecules that directly affect tumor cell proliferation and dissolution of connective tissues. These include epidermal growth factor (EGF), members of the FGF family, TGF¦Â, VEGF, chemokines, and cytokines PMID: 18325755 TAM produce several matrix metalloproteases (e.g. MMP2, MMP9) and activators of MMPs, such as chemokines.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c68 : 1
stoichiometry:c69 : 1
m34*0.1
nodelay
--
0
PMID: 18325755 TAM produce several matrix metalloproteases (e.g. MMP2, MMP9) and activators of MMPs, such as chemokines.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c71 : 1
m35*0.1
nodelay
--
0
PMID: 18325755 TAM produce several matrix metalloproteases (e.g. MMP2, MMP9) and activators of MMPs, such as chemokines.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c73 : 1
m36*0.1
nodelay
--
0
PMID: 18325755,7547226 TAM also produce factors, such as TGF¦Â, PDGF, IL-6, urokinase plasminogen activator, and tissue-type plasminogen activator (t-PA) that may cause matrix degradation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c75 : 1
m93248*0.1
nodelay
--
0
PMID: 18325755,7547226 TAM also produce factors, such as TGF¦Â, PDGF, IL-6, urokinase plasminogen activator, and tissue-type plasminogen activator (t-PA) that may cause matrix degradation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c77 : 1
m37*0.1
nodelay
--
0
PMID: 18325755,7547226 TAM also produce factors, such as TGF¦Â, PDGF, IL-6, urokinase plasminogen activator, and tissue-type plasminogen activator (t-PA) that may cause matrix degradation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c78 : 1
stoichiometry:c79 : 1
m93348*0.1
nodelay
--
0
PMID: 18325755,7547226 TAM also produce factors, such as TGF¦Â, PDGF, IL-6, urokinase plasminogen activator, and tissue-type plasminogen activator (t-PA) that may cause matrix degradation
p1
p3
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m4645*m3961*0.1
nodelay
--
0
PMID: 18325755,17324405 Interestingly, TLR4 could also be activated by endogenous ligands produced during stress or cell damage, including heat-shock protein 60, ED-A domain of fibronectin, and hyaluronan
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c81 : 1
m33*0.1
nodelay
--
0
PMID: 18325755 Chemokines have been shown to induce gene expression of various MMPs and, in particular, MMP-9 production, along with the uPA receptor
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c82 : 1
stoichiometry:c84 : 1
stoichiometry:c83 : 1
m39*m33*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c86 : 1
m1947*0.1
nodelay
--
0
PMID: 18325755,9192897 In normal macrophages CCL18 is inducible by Th2 cytokines: IL-4, IL-13, and IL-10 and recruit naive T cells by interacting with an unidentified receptor
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c88 : 1
m836*0.1
nodelay
--
0
PMID: 18325755,9192897 In normal macrophages CCL18 is inducible by Th2 cytokines: IL-4, IL-13, and IL-10 and recruit naive T cells by interacting with an unidentified receptor
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c90 : 1
m2103*0.1
nodelay
--
0
PMID: 18325755,9192897 In normal macrophages CCL18 is inducible by Th2 cytokines: IL-4, IL-13, and IL-10 and recruit naive T cells by interacting with an unidentified receptor
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c91 : 1
stoichiometry:c92 : 1
m41*0.1
nodelay
--
0
PMID: 18325755,12401408,15229479 Two other chemokines, CCL17 and CCL22, are abundantly expressed by TAM
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c94 : 1
m43*0.1
nodelay
--
0
PMID: 18325755,12401408,15229479 Two other chemokines, CCL17 and CCL22, are abundantly expressed by TAM
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c96 : 1
stoichiometry:c97 : 1
m42*m4465*0.1
nodelay
--
0
PMID: 18325755,9419219 These chemokines interact with the CCR4 receptor, expressed mostly by Th2 cells and by Treg
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c99 : 1
stoichiometry:c98 : 1
m44*0.1
nodelay
--
0
PMID: 18325755,9419219 These chemokines interact with the CCR4 receptor, expressed mostly by Th2 cells and by Treg
p39
p39
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c100 : 1
stoichiometry:c101 : 1
stoichiometry:c102 : 1
m2122*m93541*0.1
nodelay
--
0
PMID: 18325755,10702399 In particular, the RET/PTC1 oncogene activated transcriptome profile includes CSFs, which promote leukocyte recruitment and survival; IL-1, a primary inflammatory cytokine; the inflammatory mediator COX2; chemokines attracting monocytes and dendritic cells (CCL2, CCL20; angiogenic chemokines; coordinate induction and inhibition of matrix degrading enzymes and inhibitors; l-selectin; and CXCR4.
p4
p4
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m15*m13*0.1
nodelay
--
0
PMID: 18325755,12001991 Constitutive NF-¦ÊB activation, often observed in cancer cells, may be promoted by either microenvironmental signals, including cytokines, hypoxia, and reactive oxygen intermediates (ROI), or by genetic alterations
p39
p40
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c103 : 1
stoichiometry:c104 : 1
stoichiometry:c105 : 1
m2122*m49*0.1
nodelay
--
0
PMID: 18325755,10702399 In particular, the RET/PTC1 oncogene activated transcriptome profile includes CSFs, which promote leukocyte recruitment and survival; IL-1, a primary inflammatory cytokine; the inflammatory mediator COX2; chemokines attracting monocytes and dendritic cells (CCL2, CCL20; angiogenic chemokines; coordinate induction and inhibition of matrix degrading enzymes and inhibitors; l-selectin; and CXCR4.
p39
p41
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c106 : 1
stoichiometry:c107 : 1
stoichiometry:c108 : 1
m47*m93541*0.1
nodelay
--
0
PMID: 18325755,10702399 In particular, the RET/PTC1 oncogene activated transcriptome profile includes CSFs, which promote leukocyte recruitment and survival; IL-1, a primary inflammatory cytokine; the inflammatory mediator COX2; chemokines attracting monocytes and dendritic cells (CCL2, CCL20; angiogenic chemokines; coordinate induction and inhibition of matrix degrading enzymes and inhibitors; l-selectin; and CXCR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c109 : 1
stoichiometry:c110 : 1
stoichiometry:c111 : 1
m49*m47*0.1
nodelay
--
0
PMID: 18325755,10702399 In particular, the RET/PTC1 oncogene activated transcriptome profile includes CSFs, which promote leukocyte recruitment and survival; IL-1, a primary inflammatory cytokine; the inflammatory mediator COX2; chemokines attracting monocytes and dendritic cells (CCL2, CCL20; angiogenic chemokines; coordinate induction and inhibition of matrix degrading enzymes and inhibitors; l-selectin; and CXCR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c112 : 1
stoichiometry:c113 : 1
stoichiometry:c114 : 1
m49*m48*0.1
nodelay
--
0
PMID: 18325755,10702399 In particular, the RET/PTC1 oncogene activated transcriptome profile includes CSFs, which promote leukocyte recruitment and survival; IL-1, a primary inflammatory cytokine; the inflammatory mediator COX2; chemokines attracting monocytes and dendritic cells (CCL2, CCL20; angiogenic chemokines; coordinate induction and inhibition of matrix degrading enzymes and inhibitors; l-selectin; and CXCR4.
p39
p44
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c115 : 1
stoichiometry:c116 : 1
stoichiometry:c117 : 1
m48*m93541*0.1
nodelay
--
0
PMID: 18325755,10702399 In particular, the RET/PTC1 oncogene activated transcriptome profile includes CSFs, which promote leukocyte recruitment and survival; IL-1, a primary inflammatory cytokine; the inflammatory mediator COX2; chemokines attracting monocytes and dendritic cells (CCL2, CCL20; angiogenic chemokines; coordinate induction and inhibition of matrix degrading enzymes and inhibitors; l-selectin; and CXCR4.
p39
p45
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c118 : 1
stoichiometry:c119 : 1
stoichiometry:c120 : 1
m185*m93541*0.1
nodelay
--
0
PMID: 18325755,10702399 In particular, the RET/PTC1 oncogene activated transcriptome profile includes CSFs, which promote leukocyte recruitment and survival; IL-1, a primary inflammatory cytokine; the inflammatory mediator COX2; chemokines attracting monocytes and dendritic cells (CCL2, CCL20; angiogenic chemokines; coordinate induction and inhibition of matrix degrading enzymes and inhibitors; l-selectin; and CXCR4.
p39
p46
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c123 : 1
stoichiometry:c122 : 1
m185*m49*0.1
nodelay
--
0
PMID: 18325755,10702399 In particular, the RET/PTC1 oncogene activated transcriptome profile includes CSFs, which promote leukocyte recruitment and survival; IL-1, a primary inflammatory cytokine; the inflammatory mediator COX2; chemokines attracting monocytes and dendritic cells (CCL2, CCL20; angiogenic chemokines; coordinate induction and inhibition of matrix degrading enzymes and inhibitors; l-selectin; and CXCR4.
p4
p5
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m16*m13*0.1
nodelay
--
0
PMID: 18325755,12001991 Constitutive NF-¦ÊB activation, often observed in cancer cells, may be promoted by either microenvironmental signals, including cytokines, hypoxia, and reactive oxygen intermediates (ROI), or by genetic alterations
p6
p6
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m185*m13*0.1
nodelay
--
0
PMID: 18325755,12490959,15766659,15485627 In particular, pro-inflammatory cytokines (e.g. IL-1 and TNF), expressed by infiltrating leukocytes, can activate NF-¦ÊB in cancer cells and contribute to their proliferation and survival
p6
p7
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c21 : 1
stoichiometry:c20 : 1
m13*m175*0.1
nodelay
--
0
PMID: 18325755,12490959,15766659,15485627 In particular, pro-inflammatory cytokines (e.g. IL-1 and TNF), expressed by infiltrating leukocytes, can activate NF-¦ÊB in cancer cells and contribute to their proliferation and survival
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m17*m41575*0.1
nodelay
--
0
PMID: 18325755,14673019,12925853 There is now evidence that TIR8, an orphan member of the IL-1R family (also known as single immunoglobulin IL-1R-related molecule, SIGIRR) inhibits signalling from the IL-1R/TLR complexes, possibly by trapping IRAK-1 and TRAF-6
p9
p9
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
stoichiometry:c29 : 1
stoichiometry:c28 : 1
m17*m184*m183*0.1
nodelay
--
0
PMID: 18325755,14673019,12925853 There is now evidence that TIR8, an orphan member of the IL-1R family (also known as single immunoglobulin IL-1R-related molecule, SIGIRR) inhibits signalling from the IL-1R/TLR complexes, possibly by trapping IRAK-1 and TRAF-6
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--